I am a Trial Manager at the Newcastle Clinical Trials Unit, working on the AuToDeCRA 2 and E-CLAD UK studies.

Before joining the CTU, I worked as Regulatory and Engagement Manager for the CANDO (www.cando.ac.uk) project, which aims to develop an optogenetic implant to treat focal epilepsy.  I am responsible for leading on obtaining ethical and regulatory approvals and public and patient engagement including the project managing the Illuminating the Self project, an artistic response to the CANDO project. 

I started working in clinical research as a Research & Development Officer for The Newcastle upon Tyne Hospitals NHS Foundation Trust. The R&D team is part of the Newcastle Joint Research Office which sees the Trust working in conjunction with Newcastle University to support medical research. 

Qualifications

MSc with commendation Clinical Exercise Physiology, Northumbria University

BSc (hons) in Biology, Sheffield University

• White M, Whittaker RG. Post-Trial Considerations for an Early Phase Optogenetic Trial in the Human Brain. Open Access Journal of Clinical Trials 2022, 14, 1-9.
• White M, Mackay M, Whittaker RG. Taking Optogenetics into the Human Brain: Opportunities and Challenges in Clinical Trial Design. Open Access Journal of Clinical Trials 2020, 12, 33-41.
• White M, Whittaker R, Gandara C, Stoll EA. A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies. Human Gene Therapy Methods 2017, 28(4), 163-176.